SEARCH

SEARCH BY CITATION

References

  • ARONSON, J.K. (1992). Potassium channels in nervous tissue. Biochem. Pharmacol., 43, 1114.
  • BANCHELLI, G., RAIMONDI, L., GHELARDINI, C., PIRISINO, R., BERTINI, V., DE MUNNO, A. & LUCCHESINI, F. (2000). Benzylamine-related compounds stimulate rat vas deferens neurotransmission and potentiate memory in the mouse acting as potassium channel blockers. Pharmacol. Res., 41, 151162.
  • BANCHELLI, G., GHELARDINI, C., RAIMONDI, L., GALEOTTI, N. & PIRISINO, R. (2001). Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice. Eur. J. Pharmacol., 413, 9199.
  • BOOR, P.J., TRENT, M.B., LYLES, G.A., TAO, M. & ANSARI, G.A. (1992). Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase. Toxicology, 73, 251258.
  • BUFFONI, F. (1995). Semicarbazide-sensitive amine oxidases: some biochemical properties and general considerations. Prog. Brain Res., 106, 323331.
  • BUFFONI, F., BERTINI, V. & DINI, G. (1998). The mechanism of inhibition of benzylamine oxidase by 3,5-diethoxy-4-aminomethylpyridine (B24). J. Enzyme Inhibition, 13, 253266.
  • BUTTERWORTH, R.F. (1992). Pathogenesis, and treatment of portal-systemic encephalopathy: an update. Dig. Dis. Sci., 37, 321327.
  • CASTILLO, V., LIZCANO, J.M., VISA, J. & UNZETA, M. (1998). Semicarbazide-sensitive amine oxidase (SSAO) from human and bovine cerebrovascular tissues: biochemical and immunohistological characterization. Neurochem. Int., 33, 415423.
  • CHANDY, K.G., WILLIAMS, C.B., SPENCER, R.H., AGUILAR, B.A., GHANSHANI, S., TEMPEL, B.L. & GUTMAN, G.A. (1990). A family of three mouse potassium channel genes with intronless coding regions. Science, 247, 973975.
  • CHEN, X.H., ADAMS, J.U., GELLER, E.B., DERIEL, J.K., ADLER, M.W. & LIU-CHEN, L.Y. (1995). An antisense oligodeoxynucleotide to μ-opioid inhibits μ-opioid receptor agonist-induced analgesia in rats. Eur. J. Pharmacol., 275, 105108.
  • COOK, N.S. (1988). The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol. Sci., 9, 2128.
  • DAR, M.S., MORSELLI, P.L. & BOWMAN, E.R. (1985). The enzymatic systems involved in the mammalian metabolism of methylamine. Gen. Pharmacol., 16, 557560.
  • DAWSON, L.A. & ROUTLEDGE, C. (1995). Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5-HT in the striatum of conscious rats. Br. J. Pharmacol., 116, 32603264.
  • EDWARDS, G. & WESTON, A.H. (1993). The pharmacology of ATP-sensitive potassium channels. Annu. Rev. Pharmacol. Toxicol., 33, 597637.
  • EKBLOM, J. (1998). Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: vascular cytoprotection in diabetes mellitus. Pharmacol. Res., 37, 8792.
  • FINNEGAN, T.K., IRWIN, I., DELANNEY, L.E. & LANGSTON, W. (1995). Age-dependent effects of the 2′-methyl analog of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: prevention by inhibitors of monoamine oxidase B. J. Pharmacol. Exp. Ther., 237, 716720.
  • GALEOTTI, N., GHELARDINI, C., CAPACCIOLI, S., QUATTRONE, A., NICOLIN, A. & BARTOLINI, A. (1997). Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like K+channel. Eur. J. Pharmacol., 330, 1525.
  • GHELARDINI, C., GALEOTTI, N., PECORI, V.A., CAPACCIOLI, S., QUATTRONE, A. & BARTOLINI, A. (1997). Effect of K+channel modulation on mouse feeding behaviour. Eur. J. Pharmacol., 329, 18.
  • HALEY, T.J. & MCCORMICK, G.L. (1957). Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. Chemother., 12, 1215.
  • HALLIWELL, J.V. (1990). K+ channels in the central nervous system. In: Potassium channels: Structure, classification, function and therapeutic potential. ed. Cook, N. S. pp. 348381. Chichester: Ellis Horwood Limited.
  • HAMMES, H.P., BROWNLEE, M., EDELSTEIN, D., SALECK, M., MARTIN, S. & FEDERLIN, K. (1994). Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia, 37, 3235.
  • HOPKINS, W.F. & TEMPEL, B.L. (1992). Members of a mouse subfamily of genes encoding voltage-gated potassium channel subunits from heteromultimers when co expressed in Venous oocytes. Soc. Neurosci. Abstr., 18, 1093.
  • HRNJEZ, B.J., SONG, J.C., PRASAD, M., MAYOL, J.M. & MATTHEWS, J.B. (1999). Ammonia blockade of intestinal epithelial K+ conductance. Am. J. Physiol., 277, G521G532.
  • HU, S.H., WANG, S., GIBSON, J. & GILBERTSON, T.A. (1998). Inhibition of delayed rectifier K+channels by dexfenfluramine (Redux). J. Pharmacol. Exp. Ther., 287, 480486.
  • INUI, A. (2000). Transgenic approach to the study of body weight regulation. Pharmacol. Rev., 52, 3561.
  • LEWINSON, R., BOHM, H.K., GLOVER, V. & SANDLER, M. (1978). A benzylamine oxidase distinct from monoamine oxidase B. Widespread distribution in man and rat. Biochem. Pharmacol., 27, 18571863.
  • LYLES, G.A. & MCDOUGALL, S.A. (1989). The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazin may be related to the inhibition of semicarbazide-sensitive amine oxidase activities. J. Pharm. Pharmacol., 41, 97100.
  • MESZAROS, Z., SZOMBATHY, T., RAIMONDI, L., KARADI, I., ROMICS, L. & MAGYAR, K. (1999). Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism, 48, 113117.
  • MIYATA, G., MEGUID, M.M., FETISSOV, S.O., TORELLI, G.F. & KIM, H.J. (1999). Nicotine's effect on hypothalamic neurotransmitters and appetite regulation. Surgery, 126, 255263.
  • MUNDORF, M.L., HOCHSTETLER, S.E. & WIGHTMAN, R.M. (1999). Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. J. Neurochem., 73, 23972405.
  • PARADA, M.A., HERNANDEZ, L., SHWARTZ, D. & HOEBEL, B.G. (1988). Hypothalamic infusions of amphetamine increase serotonin, dopamin and norepinephrine. Physiol. Behav., 44, 607610.
  • PIRISINO, R., BANCHELLI, G., IGNESTI, G., MANTELLI, L., MATUCCI, R., RAIMONDI, L. & BUFFONI, F. (1993). Calcium modulatory properties of 2,6-dibutylbenzylamine (B25) in rat isolated vas deferens, cardiac and smooth muscle preparations. Br. J. Pharmacol., 109, 10381045.
  • PRECIOUS, E., GUNN, C.E. & LYLES, G.A. (1988). Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta. Biochem. Pharmacol., 37, 707713.
  • QUATTRONE, A., PAPUCCI, L., SCHIAVONE, N., MINI, E. & CAPACCIOLI, S. (1994). Intracellular enhancement of intact antisense oligonucleotide steady-state levels by cationic lipids. Anticancer Drug Des., 9, 549553.
  • SIMENOFF, M.L. (1975). Metabolism and toxicity of aliphatic amines. Kidney Int., 7, S314S317.
  • SNYDERS, D.J. (1999). Structure and function of cardiac potassium channels. Cardiovasc. Res., 42, 377390.
  • YU, P.H. & ZUO, D.M. (1993). Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. Diabetes, 42, 594603.
  • YU, P.H. & ZUO, D.M. (1997). Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia, 40, 12431250.
  • ZEISEL, S.H. & DACOSTA, K.A. (1986). Increase in human exposure to methylamine precursors of N-nitrosamines after eating fish. Cancer Res., 46, 61366138.